Top Markets
#1 ONFA ONFA +19.60%
#2 Wrapped Krown Wrapped Krown +17.63%
#3 DODO DODO +15.99%
#4 Islamic Coin Islamic Coin +14.95%
#5 eCash eCash +12.61%
#6 Black Phoenix Black Phoenix +11.14%
#7 Magma Finance Magma Finance +11.13%
#8 Xeffy Xeffy +11.12%
#9 Tung Tung Tung Sahur Tung Tung Tung Sahur +9.56%
#10 The Black Bull The Black Bull +8.93%
Coin of the day
ONFA ONFA
Settings
Language
ENGLISH
Currency
USD
Theme
Implanet S.A. Implanet S.A.

Implanet S.A.

ALIMP
Rank in Stocks #15768
Implanet S.A., together with its subsidiaries, researches and develops,... Implanet S.A., together with its subsidiaries, researches and develops, manufactures, and sells spinal and orthopedic implants. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. Implanet S.A. has a strategic partnership with Shanghai Sanyou Medical Co, Ltd. The company was founded in 2006 and is based in Martillac, France.
Share Price
$0.21089839
Market Cap
$30.33M
Change (1 day)
0.68%
Change (1 year)
86.95%
Country
FR
Trade Implanet S.A. (ALIMP)

Category

Healthcare
Revenue for Implanet S.A. (ALIMP)
Revenue in Dec 2025 TTM: $14.64M
According to Implanet S.A. latest financial reports the company's current revenue (TTM) is $14.64M. In 2023 the company made a revenue of $8.23M a decrease compared to the revenue in the year 2022 that was $8.61M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Implanet S.A. from 2012 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $14.64M 49.53%
2024 $9.79M 18.89%
2023 $8.23M -4.40%
2022 $8.61M 23.34%
2021 $6.98M 47.30%
2020 $4.74M -42.96%
2019 $8.31M 7.62%
2018 $7.72M -17.92%
2017 $9.41M 14.27%
2016 $8.23M 13.97%
2015 $7.22M -15.17%
2014 $8.52M -7.44%
2013 $9.20M 4.93%
2012 $8.77M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $45.13B 308,290.34%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.27B 172,564.16%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 $36.37B 248,413.04%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $20.62B 140,757.60%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.30B 42,970.38%
US